Growth Metrics

Avanos Medical (AVNS) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Avanos Medical 1.17 Bn 1.10 Bn 94.20 Mn 15.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.38%
Dec 31, 2025 10.53%
Sep 30, 2025 -162.50%
Jun 30, 2025 -123.73%
Mar 31, 2025 -355.00%
Dec 31, 2024 -109.38%
Sep 30, 2024 75.46%
Jun 30, 2024 9.23%
Mar 31, 2024 50.00%
Dec 31, 2023 1,753.06%
Sep 30, 2023 -940.43%
Jun 30, 2023 -58.54%
Mar 31, 2023 96.71%
Dec 31, 2022 -4.26%
Sep 30, 2022 2.08%
Jun 30, 2022 29.31%
Mar 31, 2022 -2,035.09%
Dec 31, 2021 7.84%
Sep 30, 2021 31.43%
Jun 30, 2021 15.94%
Mar 31, 2021 -9.62%
Dec 31, 2020 37.04%
Sep 30, 2020 87.85%
Jun 30, 2020 76.92%
Mar 31, 2020 58.40%
Dec 31, 2019 54.49%
Sep 30, 2019 -1.95%
Jun 30, 2019 -104.13%
Mar 31, 2019 -30.21%
Dec 31, 2018 -41.27%
Sep 30, 2018 -303.57%
Jun 30, 2018 11,582.54%
Mar 31, 2018 5.88%
Dec 31, 2017 -200.00%
Sep 30, 2017 -86.67%
Jun 30, 2017 96.52%
Mar 31, 2017 -27.50%
Dec 31, 2016 30.00%
Sep 30, 2016 60.73%
Jun 30, 2016 -935.43%
Mar 31, 2016 60.00%
Dec 31, 2015 41.75%
Sep 30, 2015 41.05%
Jun 30, 2015 14.63%
Mar 31, 2015 -166.67%
Dec 31, 2014 4.63%